Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Lei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8026-3665; OpenAlex author ID A5100440352. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers

Papers 3

  1. KLHDC7B-DT aggravates pancreatic ductal adenocarcinoma development via inducing cross-talk between cancer cells and macrophages. Co-author DOI 10.1042/cs20201259↗
  2. lncRNA ANRIL aggravates the chemoresistance of pancreatic cancer cells to gemcitabine by targeting inhibition of miR-181a and targeting HMGB1-induced autophagy. Co-author DOI 10.18632/aging.203251↗
  3. MTHFR polymorphisms and pancreatic cancer risk: lack of evidence from a meta-analysis. Co-author DOI 10.7314/apjcp.2012.13.5.2249↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hang Yin · 1 shared paper, 2021 · strength 0.17
  2. Lei Wang · 1 shared paper, 2021 · strength 0.17
  3. Muxing Li · 1 shared paper, 2021 · strength 0.14
  4. Chunhui Yuan · 1 shared paper, 2021 · strength 0.14
  5. Dianrong Xiu · 1 shared paper, 2021 · strength 0.14
  6. Bin Jiang · 1 shared paper, 2021 · strength 0.14
  7. Li Zhang · 1 shared paper, 2021 · strength 0.14
  8. Wei Jiang · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.